Tekla Healthcare Investors (HQH)

HEALTH CARE: HEALTH CARE
SIC: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES

100 FEDERAL STREET BOSTON, MA 02110

H&Q Healthcare Investors (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is to provide long-term capital appreciation through investment in companies in the healthcare industry. The Fund invests primarily in biotechnology, medical devices, and pharmaceuticals. The Fund invests primarily in securities of public and private companies. The Fund may enter into option contracts in order to hedge against adverse price movements in the value of portfolio assets. Selection will emphasize the smaller companies with a maximum of 40% of the Fund's assets in restricted securities of both public and private companies. Hambrecht & Quist Capital Management LLC serves as the Funds investment adviser.

Data based on most recent fiscal year report
Market Cap844.301 Million Shares Outstanding40.65 Million Avg Volume206.381 Thousand
View SEC Filings from HQH instead.
Q3 2019 All Institutions Hedge Funds 1
To trade HQH now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 90 6 (0.63%)
Aggregate 13F shares on 09/30/2019: 8.946 Million 662.647 Thousand
Aggregate 13F shares on 06/30/2019: 9.216 Million 563.597 Thousand
Percent change: -2.93% 17.57%
Funds creating new positions: 14 1
Funds Adding to an existing position: 34 3
Funds closing out their position: 8
Funds reducing their position: 23 2
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding HQH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BONNEY MICHAEL W

0 2019-11-20 0

NABEL ELIZABETH G

  • Director
0 2019-06-27 1

OMSTEAD DANIEL R PRESIDENT

  • Officer
  • Director
85,406 2018-12-26 1

REARDON WILLIAM S

  • Director
0 2018-06-20 0

POHOTSKY OLEG M

  • Director
10,000 2018-04-18 0

KENT THOMAS M

  • Director
1,100 2018-01-25 0

GASPERONI TIMOTHY L

  • SENIOR VICE PRESIDENT RESEARCH
No longer subject to file 2016-01-06 0

STEBBINS LUCINDA H

  • Director
6,513 2015-06-29 0

REINHARDT UWE E

  • Director
0 2015-06-25 0

WOODWARD LAURA F SECRETARY

  • Officer
0 2015-06-25 0

CHANG BETTY T ASSISTANT TREASURER

  • Officer
0 2009-06-11 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments